Congratulations Drs. Alshbool (PI) and Khasawneh (Co-I) for their recently awarded NIH R56 proposal (0.6M)! The study Investigates the Mechanism and Impact of E-cigarettes on Platelet Function and Thrombogenesis.
Congratulations to Dr. Dai and his team for their recent NIH-UG3 proposal received funding (2.9M) . Dr. Dai is the PI of this proposal, and this study focuses on the Allosteric targeting of Cannabinoid CB1 Receptors to Develop non-addictive small molecular analgesics.
Congratulations, Dr. Zhu, for your recently funded DOD DHA Phase II SBIR award (Molecular Rebar Design’s Discrete Multiwalled Carbon Nanotube HIV Therapy Technology). Dr. Zhu serves as an academic PI in the proposal.
Congratulations three postdoctoral scholars for winning the Spring 2022 Texas A&M Health Postdoctoral Association (PDA) awards. Jaclyn Iannucci, Department of Neuroscience and Experimental Therapeutics, College of Medicine and Vikas Chonira, Department of Microbial Pathogenesis and Immunology, College of Medicine were recipients of the two travel awards. Ahmed Alarabi, Department of Pharmacy Practice, College of Pharmacy, was the recipient of the professional development award.
Congratulations! Drs. Udeani, Joy, and Panahi ! They have been awarded $1M from the FDA ( Title: Utilizing the Pharmacy Advances Clinical Trials (PACT) Network to Achieve Diversity in COVID clinical Trials: A Strategic Framework), collaborating with AACP.
Congratulations Dr. Fatima Alshbool, for your Early Career Research Award from American Society for Pharmacology and Experimental Therapeutics (ASPET).
